Stay updated on NasoVAX Extension Safety and Immunogenicity Clinical Trial

Sign up to get notified when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NasoVAX Extension Safety and Immunogenicity Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Show glossary toggle added; QC-related fields are relabeled to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new revision tag 'Revision: v3.4.0' appears. The previous labels and tag were 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.3%
    Check dated 2026-01-28T19:22:48.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. This reflects a minor page version update.
    Difference
    0.1%
    Check dated 2026-01-14T03:49:33.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A new 'Locations' section appears with Maryland listed, and the page footer shows Revision: v3.3.3. The 'HHS Vulnerability Disclosure' link and the 'Maryland Locations' entry were removed.
    Difference
    0.3%
    Check dated 2025-12-23T22:05:49.000Z thumbnail image
  5. Check
    70 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.2.0 to v3.3.2 with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:51:44.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page removed the notice about potential delays due to government funding and operating status updates. No core study content or user actions are affected, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T07:15:12.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Visual redesign of the study details page is evident, while the underlying study data (eligibility criteria, primary and secondary outcomes, and study status) appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:12:14.000Z thumbnail image

Stay in the know with updates to NasoVAX Extension Safety and Immunogenicity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.